Voriconazole Injection, Powder, Lyophilized, For Solution
Product Images NDC 72843-441

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Voriconazole (NDC 72843-441). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ubi Pharma Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Vial Carton (Carton)

This is a description for a medication called Voriconazole, distributed by UBI Pharma Inc. The medication is in the form of a sterile single-dose vial, to be reconstituted with 19 mL of water for injection to create a solution with a recommended Voriconazole concentration of 10mg/mL. The solution must be further diluted before use, with appropriate diluents referred to in the instructions. The medication should be used for intravenous infusion only, and the unused portion should be discarded. The storage temperature should be between 20 and 25 degrees Celsius.*

FDA Label Image

Vial Label (Container)

This is a description for a drug called Voriconazole which is administered intravenously. Each mL of the drug contains 10 mg of Voriconazole and 160 mg of sulfobuty ether oyclodextin sodium (SBECD). The drug is distributed by UBI Pharma fnc, located in Hukou, Hsinchu, Taiwan. No other information is available in this text.*

FDA Label Image

Chemical Structure (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.